- Home
- VRAX vs GXAI Comparison
VRAX vs GXAI Comparison
Compare VRAX & GXAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | VRAX | GXAI |
|---|---|---|
| Founded | 2013 | 2021 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7M | 9.1M |
| IPO Year | 2021 | 2022 |
Fundamental Metrics
Financial Performance| Metric | VRAX | GXAI |
|---|---|---|
| Price | $0.18 | $1.36 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $1.00 | N/A |
| AVG Volume (30 Days) | 185.2K | ★ 9.1M |
| Earning Date | 03-10-2026 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 71.35 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $1,933,030.00 |
| Revenue This Year | $217,274.83 | $42,959.35 |
| Revenue Next Year | N/A | $100.00 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 47901.74 |
| 52 Week Low | $0.18 | $1.00 |
| 52 Week High | $1.35 | $2.96 |
Technical Indicators
Market Signals| Indicator | VRAX | GXAI |
|---|---|---|
| Relative Strength Index (RSI) | 37.26 | 49.72 |
| Support Level | N/A | $1.11 |
| Resistance Level | $0.25 | $1.38 |
| Average True Range (ATR) | 0.02 | 0.18 |
| MACD | 0.00 | -0.00 |
| Stochastic Oscillator | 4.63 | 21.53 |
Price Performance
Historical ComparisonAbout VRAX Virax Biolabs Group Limited
Virax Biolabs Group Ltd is an inventive biotechnology company focused on the detection of immune responses to and diagnosis of viral diseases. Through its ViraxImmune platform and ImmuneSelect portfolio of research-use-only (RUO) products and services, the Company is building an immune-profiling offering that spans RUO assays, preclinical immunology services and, longer term, T cell-based diagnostics aimed at post-acute infection syndromes (PAIS) such as Long COVID and other chronic conditions linked to immune dysregulation.
About GXAI Gaxos.ai Inc.
Gaxos.AI Inc is revolutionizing the way humans interact with artificial intelligence. The company offers applications related to mental and physical well-being, coaching, and gaming. The group is committed to tackling contemporary challenges such as how to live healthier and how to live longer. In addition to offering human-centered solutions, the company uses empathetic and AI technologies.